e-learning
resources
ERJ
2002
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Activation of second messenger pathways in alveolar macrophages by endotoxin
Monick M.M., Hunninghake G.W.
Source:
Eur Respir J 2002; 20: 210-222
Journal Issue:
July
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Monick M.M., Hunninghake G.W.. Activation of second messenger pathways in alveolar macrophages by endotoxin. Eur Respir J 2002; 20: 210-222
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Effect of smoking on MAP kinase-induced modulation of IL-8 in human alveolar macrophages
Source: Eur Respir J 2004; 23: 805-812
Year: 2004
Ventilation-induced activation of the mitogen-activated protein kinase pathway
Source: Eur Respir J 2002; 20: 946-956
Year: 2002
Increased expression of p38 MAPK in human bronchial epithelium after lipopolysaccharide exposure
Source: Eur Respir J 2005; 25: 797-803
Year: 2005
Group V phospholipase A
2
(gVPLA
2
) -induced eosinophil synthesis of LTC
4
is independent of mitogen-activated protein kinases (MAPK) activation
Source: Eur Respir J 2001; 18: Suppl. 33, 408s
Year: 2001
Transforming growth factor-β inhibition of lung fibroblast proliferation is mediated through prostaglandin E
2
,
via
activation of p38 mitogen-activated protein kinase
Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms
Year: 2005
Phosphoinositide 3-kinase ? inhibitor suppresses interleukin-17 expression in a murine asthma model
Source: Eur Respir J 2010; 36: 1448-1459
Year: 2010
Mitogen-activated protein-kinase modulation of NF-kappaB-induced GM-CSF release from human alveolar macrophages
Source: Eur Respir J 2003; 22: Suppl. 45, 392s
Year: 2003
Regulation of cytokine- and phorbol ester-mediated interleukin (IL)-8 expression in the absence or presence of pyocyanin in human bronchial epithelial cell line: roles of protein kinase C and mitogen-activated protein kinases
Source: Eur Respir J 2005; 26: Suppl. 49, 99s
Year: 2005
Inhibition of p38 MAPK-dependent bronchial contraction after ozone by corticosteroids
Source: Eur Respir J 2011; 37: 933-942
Year: 2011
The effects of oral p38 mitogen activated protein kinase (MAPK) inhibitor SB-681323 on blood biomarkers in COPD
Source: Annual Congress 2008 - Novel treatments for respiratory disease
Year: 2008
Stimulation of NOD1 induces RIP2, TAK1 and p38 MAPK dependent pro-inflammatory signalling in human lung microvascular endothelial cells
Source: Annual Congress 2011 - Mechanisms of acute lung injury and mesenchymal cell treatment
Year: 2011
Inhibition of phosphatidylinositol 3-kinase and mitogen-activated protein kinase kinase prevents malignant pleural mesothelioma cell growth
Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology
Year: 2010
N-acetylcysteine reduces chemokine release via inhibition of p38 MAPK in human airway smooth muscle cells
Source: Eur Respir J 2003; 22: 43-49
Year: 2003
Transmission of muscarinic receptor mediated proliferative effects in human lung fibroblasts involves ERK-MAP kinase, but not PI-3 kinase and Rho-kinase pathway
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology
Year: 2007
Thrombin activates mitogen activated protein (MAP) kinase and activated protein-1 (AP-1) to induce interleukin-8 (IL-8) release from airway epithelial cells
Source: Annual Congress 2003 - Mechanisms of lung injury: from bench to bedside
Year: 2003
Corticosteroids reduce pro-inflammatory cytokine expression in airway smooth muscle cells via upregulation of MAPK phosphatase-1 and inhibition of p38 MAPK signalling
Source: Eur Respir J 2005; 26: Suppl. 49, 713s
Year: 2005
Increased phosphorylated p38 mitogen-activated protein kinase in COPD lungs
Source: Eur Respir J 2013; 42: 28-41
Year: 2013
Effect of fudosteine on mucin production
Source: Eur Respir J 2008; 32: 1195-1202
Year: 2008
Effects of glucocorticoids on activation of extracellular signal-regulated kinases (ERK) in human pulmonary endothelial cells
Source: Eur Respir J 2001; 18: Suppl. 33, 160s
Year: 2001
Constitutive phosphorylation of p38 mitogen activated protein kinase controls proliferation of mesothelioma cells
Source: Eur Respir J 2005; 26: Suppl. 49, 225s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept